Big Gain For Dermata Therapeutics Inc.
Dermata Therapeutics Inc. (DRMA:NASDAQ) jumped higher at $2.61, a gain of 35.2%. On Fri, May 12, 2023, DRMA:NASDAQ touched a New 2-Week High of $2.61. The stock got featured on our News Catalysts scanner on Thu, May 11, 2023 at 04:52 PM in the 'INVESTOR UPDATE' category. From Fri, Apr 28, 2023, the stock recorded 60.00% Up Days and 45.45% Green Days
The stock spiked on Fri, May 12, 2023 at $3.68 with a volume of 38M+.
About Dermata Therapeutics Inc. (DRMA:NASDAQ)
Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.
Top 10 Gainers:
- GSI Technology, Inc. (GSIT:NASDAQ), 210.37%
- ARS Pharmaceuticals Inc Com (SPRY:NASDAQ), 77.88%
- Getaround Inc. (GETR:NYSE), 45%
- Meihua International Medical Technologies Co. Ltd. (MHUA:NASDAQ), 42.37%
- ImmunoPrecise Antibodies Ltd. (IPA:NASDAQ), 39.79%
- AirSculpt Technologies Inc. (AIRS:NASDAQ), 37.42%
- Blue Bird Corporation (BLBD:NASDAQ), 36.28%
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 35.23%
- DIRTT Environmental Solutions Ltd. (DRTT:NASDAQ), 32.35%
- BurgerFi International Inc (BFI:NASDAQ), 30%